Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top